» Articles » PMID: 23223012

The Trend in Morning Levels of Salivary Cortisol in Children With ADHD During 6 Months of Methylphenidate Treatment

Overview
Journal J Atten Disord
Publisher Sage Publications
Specialty Psychiatry
Date 2012 Dec 11
PMID 23223012
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the trend in cortisol levels in children with ADHD treated with methylphenidate (MPH) and nontreated healthy controls over a 6-month period.

Method: The morning salivary cortisol levels of 50 patients with ADHD (40 boys and 10 girls, mean age = 7.6 years) and 50 age- and gender-matched healthy controls were measured at baseline and at 1, 3, and 6 months from baseline. The neuropsychological performance of the ADHD patients was measured via administration of the Continuous Performance Test.

Results: The cortisol levels of ADHD patients increased significantly after 1 month of MPH treatment before decreasing to an intermediate level, but were significantly positively correlated with neuropsychological performance throughout the 6-month treatment period. The cortisol levels of the controls did not change significantly over the 6-month period.

Conclusion: MPH administration appears to positively influence the functioning of the hypothalamic-pituitary-adrenal axis in ADHD patients.

Citing Articles

Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment.

Garre-Morata L, Haro T, Villen R, Fernandez-Lopez M, Escames G, Molina-Carballo A Antioxidants (Basel). 2024; 13(1).

PMID: 38247516 PMC: 10812591. DOI: 10.3390/antiox13010092.


A bidirectional Mendelian randomization study about the role of morning plasma cortisol in attention deficit hyperactivity disorder.

Jue H, Fang-Fang L, Dan-Fei C, Nuo C, Chun-Lu Y, Ke-Pin Y Front Psychiatry. 2023; 14:1148759.

PMID: 37389173 PMC: 10303788. DOI: 10.3389/fpsyt.2023.1148759.


Long-term cortisol secretion in attention deficit hyperactivity disorder: roles of sex, comorbidity, and symptom presentation.

Pauli-Pott U, Skoluda N, Nater U, Becker K, Derz F, Kaspar E Eur Child Adolesc Psychiatry. 2023; 33(2):569-579.

PMID: 36917355 PMC: 10869441. DOI: 10.1007/s00787-023-02180-1.


ADHD symptoms and diurnal cortisol in adolescents: The importance of comorbidities.

Berens A, LeMoult J, Kircanski K, Gotlib I Psychoneuroendocrinology. 2022; 148:105990.

PMID: 36462296 PMC: 10193285. DOI: 10.1016/j.psyneuen.2022.105990.


Approaches to Identify Factors Associated with Pubertal Timing in Self-Limited Delayed Puberty.

Zhu J, Liu E, Feld A, Jonsdottir-Lewis E, Shirey A, Feldman H Horm Res Paediatr. 2022; 96(3):267-277.

PMID: 36007499 PMC: 9958281. DOI: 10.1159/000526590.